In KRAS-mutant lung cancer patients, M2 macrophages, MDSCs, CD4+FoxP3+ Treg cells, IL-17-producing T helper cells displayed a pro-tumorigenic TME (Cullis et al., 2018). Here, KRAS is linked to lung carcinoma.